Shikonin improves intestinal barrier function through modulation of GPX4 expression in intestinal epithelial cells
International Journal of Immunopathology and Pharmacology · 2026
DOI: 10.1177/03946320261427239 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunopathology and Pharmacology, 2026. Verfasst von Fuheng Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhuhai Women and Children's Hospital, Zhuhai, China. Hauptthemen laut MEDLINE: Intestinal Barrier Function, Naphthoquinones, Epithelial Cells, Phospholipid Hydroperoxide Glutathione Peroxidase. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Traditional Chinese medicine grant in Guangdong.
Abstract (Originalsprache)
Shikonin has been reported to regulate caudal-type homeobox 2 (CDX2)-mediated intestinal epithelial cell (IEC) differentiation, and ferroptosis has been identified a critical event during this process. However, the exact role of ferroptosis in shikonin-induced IEC differentiation remains unclear. Accordingly, the aim of this study was to elucidate the involvement of ferroptosis in CDX2-mediated IEC differentiation induced by shikonin. Real-time polymerase chain reaction, western blotting, luciferase assay, immunoprecipitation, and chromatin immunoprecipitation were used to reveal the mechanism underlying shikonin-modulated ferroptosis-dependent IEC differentiation in HT-29 and Caco-2 cells. Shikonin treatment reduced ferroptosis in IECs, as evidenced by the increased expression of glutathione peroxidase 4 (GPX4) and solute carrier family 7 (cationic amino acid transporter) member 11, which enhanced CDX2 expression and improved IEC barrier function. Mechanistically, shikonin activated the protein kinase A (PKA)/cAMP-responsive element-binding protein (CREB) signaling cascade, promoting CREB binding to the GPX4 promoter and initiating GPX4 transactivation. GPX4 inhibition reversed the effects of shikonin on CDX2 expression. Endogenous pyruvate kinase isozyme M2 interacted with phosphodiesterase 4; this interaction was disrupted by shikonin, leading to the activation of PKA/CREB signaling. The findings of this study indicate that a low dose of shikonin improves IEC barrier function through GPX4-mediated inhibition of ferroptosis, highlighting its potential as a therapeutic agent for intestinal mucosal injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Zhuhai Women and Children's Hospital, Zhuhai, China.
- Department of Traditional Chinese Medicine, Zhuhai Women and Children's Hospital, Zhuhai, China.
- Department of Pediatric Digestive and Infection, Zhuhai Women and Children's Hospital, Zhuhai, China.
- Institute of Genetic Medicine, Zhuhai Women and Children's Hospital, Zhuhai, China.
- Department of Pediatric Hematology and Rheumatology, Zhuhai Women and Children's Hospital, Zhuhai, China.
ORCID-Profile: Xiufu Tang
Förderung
- Traditional Chinese medicine grant in Guangdong
Zitieren
APA
Yang, F., Liang, P., Guo, H., Yan, W., Wang, G., Tang, X., & Liang, Z. (2026). Shikonin improves intestinal barrier function through modulation of GPX4 expression in intestinal epithelial cells. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/03946320261427239
Vancouver
Yang F, Liang P, Guo H, Yan W, Wang G, Tang X, et al. Shikonin improves intestinal barrier function through modulation of GPX4 expression in intestinal epithelial cells. International Journal of Immunopathology and Pharmacology. 2026. doi:10.1177/03946320261427239
BibTeX
@article{Yang2026,
author = {Yang, Fuheng and Liang, Peihua and Guo, Hengli and Yan, Weizhao and Wang, Gen and Tang, Xiufu and Liang, Zhen},
title = {Shikonin improves intestinal barrier function through modulation of GPX4 expression in intestinal epithelial cells},
journal = {International Journal of Immunopathology and Pharmacology},
year = {2026},
doi = {10.1177/03946320261427239}
}
EUVIMED